PlexusDx emphasizes biomarker-informed decisions over generic supplementation protocols
Schimmer AD, O'Brien S, Kantarjian H, Brandwein J, Cheson BD, Minden MD, Yee K, Ravandi F, Giles F, Schuh A, Gupta V, Andreeff M , Koller C, Chang H, Kamel-Reid S, Berger M, Viallet J, Borthakur G
Each capsule delivers a precise 500 mcg total of the synergistic BPC-157 and TB-500 combination in a convenient, stable oral capsule form.Key Research Compound Highlights BPC-157 (Body Protection Compound-157): A synthetic pentadecapeptide derived from human gastric juice, widely studied in preclinical models for its cytoprotective, angiogenic, and anti-inflammatory properties
BPX- and PFAS-treated SIHUMIx resulted in decreased expression of TNF-, CD69, CD154, and CD107a from CD8 + MAIT cells compared to untreated SIHUMIx at most time points after chemical treatment ( Figure 5 , Supplementary Figure 3 )